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Results: On average, outlier cleaning (ModelUC vs ModelC) 
had minimal impact on HIB/HIE and OAR sparing, although in 
1/10 patients, outlier removal resulted in substantial 
deteriorations to the sparing of two swallowing OAR (>10Gy 
increase). Adding 5/10 outliers to the model marginally 
improved average compsal while increasing the number of 
outliers to 40 led to a 3.9Gy increase in compsal (Table). The 
increase in OAR dose, even with 40 outlier plans added to the 
model, was modest compared to the average increase of 
14.9Gy in compsal, in the outlier plans themselves. This is 
due to the placement of optimization objectives along the 
lower boundary of the DVH prediction range, which 
progressively widened with the addition of outliers. 
 
 
 
Conclusion: This study reveals that extensive outlier cleaning 
from this large model comprising 70 consistently made plans 
had limited impact on the performance of RP. Furthermore, 
the replacement of >20 plans with those in which the salivary 
glands were not spared only modestly deteriorated RP 
performance. In summary, RP demonstrated robustness for 
moderate proportions of salivary gland dosimetric outliers. 
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Purpose or Objective: We examined the feasibility of 
reducing PTV margin when using a simultaneous integrated 
boost (SIB) of pathological lymph nodes in locally advanced 
cervical cancer. Additionally the clinical performance of a 
coverage probability (CovP) planning strategy was 
investigated.  
 
Material and Methods: 25 previously treated patients with 
regional lymph node metastases were included. All patients 
were treated with whole pelvic EBRT (45 Gy/25 fx) using 
IMRT or VMAT. Nodal GTV contouring was based on MRI in 
supine treatment position. A CTV-N was constructed based on 
the combined (fused) nodal GTV-N contoured on MRI and PET-
CT. Treatment planning was performed in Eclipse with three 
margin strategies for the SIB: 1) 10 mm GTV-PTV margin 
(ICRU PTV10mm plan), 2) 5 mm CTV-PTV (ICRU PTV5mm plan) 
and 3) 5 mm CTV-PTV margin using CovP (CovP plan). 
Constraints for the ICRU plans (1+2): PTV coverage of 95-107% 
of prescribed dose. Running a number of CovP plans in the 
research dose planning software Hyperion developed dose 
constraints for CovP planning in Eclipse. CovP dose 
constraints: PTV5mm D98 >90%, CTV D98 > 100% and a soft 
constraint of CTV D50 > 101.5% of prescribed dose (Figure 1). 
Dose prescription for SIB was 55 Gy/25 fx in the true pelvis 
and 57.5 Gy/25 fx above true pelvis. Daily image-guidance 
with cone beam CT (CBCT) and couch correction based on 
bony fusion was used systematically. GTV-N was contoured on 
every second or third CBCT scan and the contour transferred 
to the planning CT. The accumulated dose for each node was 
determined in terms of D98 and Dmax. Finally, the volumes 
of body, bones and bowel receiving >50 Gy (V50) were 
calculated directly from organs at risk (OAR) contours on the 
planning CT. 
 
 
Results: In total 47 lymph nodes were boosted of which 41 
(87%) were visible on CBCT. Median number of nodes per 
patient was 2 (range 1-4). Median GTV D98 and Dmax (%) are 
listed in Table 1. All nodes treated with ICRU plans had a D98 
above 98% and no difference was found between the ICRU 
plans with regard to target coverage. For CovP the D98 was 
significantly lower but Dmax significantly higher when 
compared to the two ICRU plans. Only one node positioned in 
the true pelvis had a D98 below 95% using CovP. In this 
patient, bladder filling varied during EBRT, which resulted in 
large shifts of GTV-N. V50 of body, bones and bowel were 
significantly lower (p<0.001) with the 5mm margin strategy. 
A further significant reduction was seen with the use of CovP 
(p<0.001). 
 
 
Conclusion: Pathological nodes are visible on CBCT in the 
majority of patients with locally advanced cervical cancer. 
Sequential analysis of CBCT taken during EBRT shows that 
nodal boosting by use of SIB and CovP is clinically feasible 
providing an increased central dose in the nodes, full target 
coverage and a significant reduction in near by OAR volumes 
treated to high doses. CovP based SIB using the above 
planning aims are now standard at our institution for nodal 
boosting and will be implemented in the forthcoming 
Embrace II study. 
 
 
 
 
